These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23928528)

  • 1. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
    Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].
    Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
    Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
    Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
    Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
    Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
    Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma.
    Lin CW; Chen YH; Chuang YC; Liu TY; Hsu SM
    Blood; 2003 Oct; 102(7):2623-31. PubMed ID: 12816864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
    Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Guo WW; Chen LH; Yin W; Mo LX
    Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Testicular Extranodal NK/T-Cell Lymphoma: A Clinicopathologic Study of 21 Cases With Review of Additional 18 Cases in the Literature.
    Huang Y; Shi X; Zhong P; Wang Y; Xiao H; Zhou X; Yun J
    Am J Surg Pathol; 2019 Apr; 43(4):549-558. PubMed ID: 30589649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of mTOR and 4E-BP1 in extranodal Nasal-type NK/T-cell Lymphoma and implication for prognosis].
    Zhang Q; Liu G; Hang W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):123-127. PubMed ID: 30808136
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nasal and pharyngeal non-Hodgkin lymphomas and their relationship with Epstein-Barr virus: a report of 158 cases].
    He YJ; Jia XS; Hasui K; Wang EH; He AG
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):94-7. PubMed ID: 17493382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study.
    Pongpruttipan T; Sukpanichnant S; Assanasen T; Wannakrairot P; Boonsakan P; Kanoksil W; Kayasut K; Mitarnun W; Khuhapinant A; Bunworasate U; Puavilai T; Bedavanija A; Garcia-Herrera A; Campo E; Cook JR; Choi J; Swerdlow SH
    Am J Surg Pathol; 2012 Apr; 36(4):481-99. PubMed ID: 22314189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
    Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
    Sakata K; Someya M; Omatsu M; Asanuma H; Hasegawa T; Ichimiya S; Hareyama M; Himi T
    BMC Cancer; 2007 Dec; 7():229. PubMed ID: 18093334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
    Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
    Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.